Clinical Trial Biological Use Authorization (BUA) application

First published on

01/22/2018 - 16:30

Complete the Clinical Trial Biological Use Authorization (BUA) application for new and renewal projects to obtain approval for research involving recombinant DNA in human subjects. Submit Clinical Trial BUA applications at least eight weeks prior to the IBC meeting. Electronic submissions to ehsbio@uw.edu are preferred. Submit via campus mail to EH&S at Box 357165 or by fax to 206.221.3068.